This indicates that JW-SZRT can regulate the expression of 5-HT1a and 5-HT2a receptor subtypes mRNA in the hypothalamus of perimenopausal insomnia rats to achieve the therapeutic effect of insomnia. The gene discussed is HTR1A; the disease is insomnia.